Klinixa transforms how clinical trials are designed, executed and optimized combining advanced AI, Machine Learning and Deep Learning based autonomy across Drug Discovery, Precision and Translational Science, Clinical Development, Regulatory Submission and Commercial along with patient-centric intelligence to help pharma, biotech and CROs move faster with confidence.
The industry loses billions every year to avoidable delays, poor enrollment, and fragmented data. Klinixa was built to fix that.
Patients and sites are mismatched, eligibility criteria are unclear, and discovery is fragmented across dozens of disconnected registries — delaying most studies before they even begin.
Overly complex protocols drive operational burden before the first patient enrolls. Poor feasibility analysis leads to costly amendments that compound over time.
Teams work across disconnected EDC, CTMS, and reporting tools. Without harmonized, standards-aligned data, compliance rework consumes entire teams and delays submissions.
Klinixa brings intelligence, automation, and patient insight into a single cohesive system — not a patchwork of point solutions.
AI-driven protocol analysis that identifies risks, complexity, and enrollment challenges before a study begins — reducing costly amendments downstream.
Smarter trial designFrom protocol and CRF generation to SDTM/ADaM datasets and CSR-ready outputs — fully automated with complete traceable lineage throughout.
Faster executionCDISC-aligned data models, automated validation, and end-to-end traceability built directly into your workflows — not bolted on at submission.
Audit-ready by defaultAI-powered patient-to-trial matching with eligibility confidence scoring — reducing screen failures and giving patients transparent, honest guidance about their fit.
Higher success ratesExecutive dashboards and predictive analytics for portfolio prioritization, competitive benchmarking, and investment decision support across your pipeline.
Confident decisionsAI/ML-powered real-time data review, advanced biostatistics, and deep learning quality prediction — so your team focuses on results, not manual rework.
Quality at speedClinical, real-world, genomic, and operational data unified into a CDISC-aligned repository — EHR, EDC, registries, and more.
LLMs, predictive ML, and agent-based orchestration drive protocol optimization, patient matching, feasibility prediction, and decision analytics.
Automated outputs flow from protocol design through execution to submission — with full traceability and compliance embedded throughout.
Real outcomes from teams who moved from reactive to intelligent.
A leading pharmaceutical company needed to scale statistical analysis across 18 concurrent studies with tight timelines and strict CDISC requirements.
Klinixa embedded AI-assisted programming and standards automation directly within the client's team — delivering consistent, audit-ready outputs at pace.
A rapidly growing biotech faced data quality bottlenecks and slow query resolution cycles that were delaying database locks by weeks across four therapeutic areas.
Klinixa's AI-powered data review platform automated real-time issue detection and triage — cutting resolution cycles and enabling faster, cleaner locks.
A CRO managing a rare CNS indication was experiencing a 68% screen failure rate — threatening the study timeline and costing hundreds of thousands per enrolled patient.
Klinixa's eligibility-aware matching with confidence scoring pre-screened candidates before site contact, surfacing only high-probability matches with transparent rationale.
Whether you're optimizing trial design, accelerating enrollment, or transforming your data ecosystem — Klinixa helps you move faster with confidence.
Klinixa was founded in 2018 in New Jersey with one belief: when a patient is facing illness, the last thing they should struggle with is navigating a broken clinical trial system.
We saw families spending countless hours searching for trials, only to find they never qualified. We saw sponsors struggling to enroll the right patients on time. We saw data teams buried in manual rework instead of focusing on science. We built Klinixa to change all three at once.
Today, Klinixa is a global provider of advanced clinical analytics, AI-powered automation, and patient intelligence — serving pharmaceutical companies, biotech innovators, and CROs worldwide.
"To redefine clinical development by making trials more intelligent, efficient, and patient-centric — reducing waste, accelerating innovation, and improving success rates across the industry."
We build free patient-facing tools and we will never commercialise patient data.
Our team combines decades of clinical research expertise with cutting-edge AI and ML.
ISO-certified infrastructure, privacy-first architecture, and full auditability at every step.
We translate complex eligibility criteria into plain language so patients understand their options — not just their limitations. We are not here to sell hope. We are here to provide clarity.
Behind every trial is a patient. Our platform is designed to respect the physical and emotional realities people face during difficult moments — private, supportive, and human.
Our ISO-certified infrastructure and privacy-first data architecture are built to safeguard patient data, maintain regulatory integrity, and earn trust from all stakeholders.
Whether you're a pharma innovator, a CRO, or a patient — Klinixa was built for you.
Every Klinixa service is AI-native — not adapted from legacy workflows. Deploy them individually or as one unified platform.
Design smarter trials before they begin.
→ More feasible, patient-friendly trial designs with fewer costly amendments
From concept to submission — fully streamlined.
→ Faster study execution at significantly reduced operational cost
Built-in compliance. Not bolted on.
→ Audit-ready, high-quality data with minimal rework at submission time
Matching the right patient to the right trial — globally.
→ Faster enrollment, improved patient experience, and higher trial success rates
A data powerhouse — AI-driven.
→ Your team focuses on quality and insight — not manual review cycles
Quality outputs, faster.
→ Technology that works for your biostatistics team, not against it
Unified safety data. In real time.
→ Medical monitors can protect patients proactively — not reactively
Turn complex data into confident decisions.
→ Smarter decisions that accelerate development and maximize pipeline ROI
| Capability | Klinixa | Medidata / IQVIA | Tempus / Flatiron |
|---|---|---|---|
| AI-native architecture | ✓ | ✗ | ~ |
| End-to-end clinical coverage | ✓ | ~ | ✗ |
| Patient eligibility matching | ✓ | ✗ | ~ |
| Protocol intelligence | ✓ | ✗ | ✗ |
| CDISC-native automation | ✓ | ~ | ✗ |
Let us show you how the platform fits your specific challenges — one use case or the full platform.
When we founded Klinixa in 2018, the problem seemed deceptively simple: patients couldn't find the right trials, and sponsors couldn't find the right patients. But as we dug deeper, we realized the challenge was far more systemic.
Protocols were being designed in isolation — without the benefit of real-world data, predictive modeling, or honest feasibility analysis. Clinical teams were buried in manual processes that technology had long been capable of automating. And the data flowing through the system — rich, potentially life-saving data — was fragmented, inconsistently standardized, and deeply underutilised.
The industry did not lack data. It lacked intelligence.
That insight became the foundation of everything we have built. Klinixa is not a workflow tool with AI features added on top. It is an intelligence layer — purpose-built for clinical development, designed from first principles around the problems that actually slow trials down and drive costs up.
Today, I am proud of what our team has created: a platform that can analyse a protocol before the first patient is enrolled, predict which sites will perform, match patients with genuine precision, automate the data workflows that consume entire teams, and surface the insights that executives need to make confident pipeline decisions — all in one coherent system.
But what I am most proud of is our commitment to patients. From the beginning, we resolved that patient-facing tools would be free, private, and honest. We will not sell false hope. We will not commercialise patient data. We will only tell a patient they are likely eligible when the data genuinely supports it.
The future of clinical development is predictive, not reactive. It is patient-centric, not sponsor-centric. And it is intelligent — not merely automated. That future is what Klinixa is building. I invite you to be part of it.
Whether you're ready for a demo, exploring a partnership, or simply curious — we'd love to hear from you.
Our clinical and commercial team responds to all enquiries within one business day. For patient-specific queries, our team includes clinical research experts who understand your situation.
New Jersey, USA
Founded 2018
hello@klinixa.ai
partners@klinixa.ai
Free, private, and confidential
patients@klinixa.ai
Our patient discovery tools are completely free. We will never share or commercialise your health data. Contact us or visit our patient portal to get started.